Cite
MLA Citation
Kevin Smart et al.. “PK/PD Mediated Dose Optimization of Emactuzumab, a CSF1R Inhibitor, in Patients With Advanced Solid Tumors and Diffuse‐Type Tenosynovial Giant Cell Tumor.” Clinical pharmacology & therapeutics, vol. 108, no. 3, 2020, pp. 616–624. http://access.bl.uk/ark:/81055/vdc_100106634735.0x00005a